UBS AM’s Seagen Inc. Common Stock SGEN Stock Holding History

UBS AM’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-741,608	Closed	-$157M	–	2623
2023 Q3	$157M	Sell	741,608 -19,401	-3%	-$3.88M	0.07%	288
2023 Q2	$154M	Hold	761,009	–	–	0.07%	288
2023 Q1	$154M	Buy	761,009 +24,321	+3%	+$3.9M	0.07%	288
2022 Q4	$94.7M	Sell	736,688 -4,745	-0.6%	-$612K	0.05%	397
2022 Q3	$101M	Buy	741,433 +16,558	+2%	+$2.7M	0.06%	366
2022 Q2	$128M	Sell	724,875 -78,866	-10%	-$11.4M	0.07%	315
2022 Q1	$116M	Sell	803,741 -759,174	-49%	-$103M	0.05%	390
2021 Q4	$242M	Buy	1,562,915 +281,872	+22%	+$47.2M	0.09%	233
2021 Q3	$218M	Buy	1,281,043 +35,553	+3%	+$5.53M	0.09%	231
2021 Q2	$197M	Buy	1,245,490 +279,376	+29%	+$41.5M	0.08%	260
2021 Q1	$134M	Buy	+966,114	New	+$156M	0.06%	343
2020 Q4	–	Sell	-312,635	Closed	-$61.2M	–	2598
2020 Q3	$61.2M	Sell	312,635 -443,465	-59%	-$74.2M	0.03%	461
2020 Q2	$128M	Buy	756,100 +24,543	+3%	+$3.66M	0.08%	248
2020 Q1	$84.4M	Buy	731,557 +65,423	+10%	+$7.24M	0.06%	313
2019 Q4	$76.1M	Buy	666,134 +170,719	+34%	+$18.1M	0.05%	414
2019 Q3	$42.3M	Buy	495,415 +4,147	+0.8%	+$304K	0.03%	563
2019 Q2	$34M	Buy	491,268 +2,813	+0.6%	+$197K	0.02%	630
2019 Q1	$35.8M	Sell	488,455 -209,111	-30%	-$14.9M	0.03%	584
2018 Q4	$39.5M	Buy	697,566 +9,945	+1%	+$624K	0.03%	521
2018 Q3	$53M	Sell	687,621 -13,710	-2%	-$1.01M	0.04%	476
2018 Q2	$46.6M	Sell	701,331 -60,640	-8%	-$3.47M	0.04%	524
2018 Q1	$39.9M	Buy	761,971 +35,888	+5%	+$1.96M	0.03%	568
2017 Q4	$38.8M	Buy	726,083 +172,224	+31%	+$10.1M	0.03%	534
2017 Q3	$30.1M	Buy	553,859 +178,217	+47%	+$9.12M	0.03%	608
2017 Q2	$19.4M	Buy	375,642 +159,227	+74%	+$10.1M	0.02%	749
2017 Q1	$13.6M	Buy	216,415 +27,710	+15%	+$1.73M	0.01%	829
2016 Q4	$9.96M	Buy	188,705 +104,557	+124%	+$6.29M	0.01%	867
2016 Q3	$4.54M	Sell	84,148 -1,000	-1%	-$47.4K	﹤0.01%	1050
2016 Q2	$3.44M	Buy	85,148 +3,200	+4%	+$122K	﹤0.01%	1144
2016 Q1	$2.88M	Sell	81,948 -7,043	-8%	-$237K	﹤0.01%	1216
2015 Q4	$3.99M	Buy	88,991 +4,160	+5%	+$173K	﹤0.01%	1153
2015 Q3	$3.27M	Sell	84,831 -393,812	-82%	-$17.7M	﹤0.01%	1205
2015 Q2	$23.2M	Sell	478,643 -667,950	-58%	-$27.6M	0.02%	667
2015 Q1	$40.5M	Buy	1,146,593 +238,896	+26%	+$8.15M	0.04%	481
2014 Q4	$29.2M	Buy	907,697 +160,700	+22%	+$5.6M	0.03%	595
2014 Q3	$27.8M	Buy	746,997 +599,429	+406%	+$23.6M	0.03%	596
2014 Q2	$5.64M	Sell	147,568 -7,595	-5%	-$287K	0.01%	1006
2014 Q1	$7.07M	Sell	155,163 -27,699	-15%	-$1.32M	0.01%	949
2013 Q4	$7.29M	Sell	182,862 -78,328	-30%	-$3.2M	0.01%	916
2013 Q3	$11.4M	Buy	261,190 +7,132	+3%	+$297K	0.01%	774
2013 Q2	$7.99M	Buy	+254,058	New	+$8.86M	0.01%	836

Other funds holding SGEN

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

FBC

Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

UBS AM's SGEN Position: Q4 2023 in Review

UBS AM sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 741,608 shares — an estimated $157M sold.

UBS AM first reported a position in SGEN in Q2 2013 and held it in 41 quarters. The position peaked at $242M in Q4 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

UBS AM reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
UBS AM sold 741,608 Seagen Inc. Common Stock shares in Q4 2023, an estimated $157M.
UBS AM first reported a position in Seagen Inc. Common Stock in Q2 2013 and held it in 41 quarters.
UBS AM's Seagen Inc. Common Stock position peaked at $242M in Q4 2021.
6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on UBS AM's 13F filing for Q4 2023, filed 14 Feb 2024.